These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34372879)

  • 1. The impact of gender and the social determinants of health on the clinical course of people living with HIV in Myanmar: an observational study.
    Nyein PP; Aung E; Aung NM; Kyi MM; Boyd M; Lin KS; Hanson J
    AIDS Res Ther; 2021 Aug; 18(1):50. PubMed ID: 34372879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV care in Yangon, Myanmar; successes, challenges and implications for policy.
    Aung NM; Hanson J; Kyi TT; Htet ZW; Cooper DA; Boyd MA; Kyi MM; Saw HA
    AIDS Res Ther; 2017 Mar; 14(1):10. PubMed ID: 28257647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy.
    Saracino A; Zaccarelli M; Lorenzini P; Bandera A; Marchetti G; Castelli F; Gori A; Girardi E; Mussini C; Bonfanti P; Ammassari A; d'Arminio Monforte A;
    BMC Public Health; 2018 Jul; 18(1):870. PubMed ID: 30005709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to anti-retroviral therapy among people living with HIV enrolled into care in Myanmar: how prepared are we for 'test and treat'?
    Linn KZ; Shewade HD; Htet KKK; Maung TM; Hone S; Oo HN
    Glob Health Action; 2018; 11(1):1520473. PubMed ID: 30499382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of routine viral load testing among people living with HIV and its implementation challenges in Yangon region of Myanmar: a mixed-methods study.
    Thinn KK; Thekkur P; Kyaw NTT; Aye NS; Zaw TM; Soan P; Hone S; Oo HN
    BMJ Open; 2019 Dec; 9(12):e032678. PubMed ID: 31796489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of virological failure among people living with HIV receiving first line antiretroviral treatment in Myanmar: retrospective cohort analysis.
    Mesic A; Spina A; Mar HT; Thit P; Decroo T; Lenglet A; Thandar MP; Thwe TT; Kyaw AA; Homan T; Sangma M; Kremer R; Grieg J; Piriou E; Ritmeijer K; Van Olmen J; Lynen L; Oo HN
    AIDS Res Ther; 2021 Apr; 18(1):16. PubMed ID: 33882962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with death and loss to follow-up in children on antiretroviral care in Mingalardon Specialist Hospital, Myanmar, 2006-2016.
    Kaung Nyunt KK; Han WW; Satyanarayana S; Isaakidis P; Hone S; Khaing AA; Nguyen Binh H; Oo HN
    PLoS One; 2018; 13(4):e0195435. PubMed ID: 29621302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.
    Thit SS; Aung NM; Htet ZW; Boyd MA; Saw HA; Anstey NM; Kyi TT; Cooper DA; Kyi MM; Hanson J
    BMC Med; 2017 Aug; 15(1):145. PubMed ID: 28774293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Success With Retention in Care Among People Living With HIV at Decentralized ART Satellite Sites in Yangon, Myanmar, 2015-2016.
    Htet KM; Soe KT; Oo MM; Hone S; Majumdar SS; Oo HN
    Front Public Health; 2019; 7():124. PubMed ID: 31179261
    [No Abstract]   [Full Text] [Related]  

  • 11. Attrition among HIV positive children enrolled under integrated HIV care programme in Myanmar: 12 years cohort analysis.
    Minn AC; Kyaw NTT; Aung TK; Mon OM; Htun T; Oo MM; Moe J; Mon AA; Satyanarayana S; Oo HN
    Glob Health Action; 2018; 11(1):1510593. PubMed ID: 30191749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study.
    Glass TR; Günthard HF; Calmy A; Bernasconi E; Scherrer AU; Battegay M; Steffen A; Böni J; Yerly S; Klimkait T; Cavassini M; Furrer H
    Clin Infect Dis; 2021 Apr; 72(8):1413-1421. PubMed ID: 32157270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes of hospitalisation among a cohort of people with HIV from a London centre followed from 2011 to 2018.
    Rein SM; Lampe FC; Chaloner C; Stafford A; Rodger AJ; Johnson MA; McDonnell J; Burns F; Madge S; Miners A; Sherr L; Collins S; Speakman A; Phillips AN; Smith CJ
    BMC Infect Dis; 2021 Apr; 21(1):395. PubMed ID: 33926373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced HIV disease and associated attrition after re-engagement in HIV care in Myanmar from 2003 to 2019: a retrospective cohort study.
    Mesic A; Homan T; Lenglet A; Thit P; Mar HT; Sabai SM; Thandar MP; Thwe TT; Kyaw AA; Decroo T; Spina A; Ariti C; Ritmeijer K; Van Olmen J; Oo HN; Lynen L
    Int Health; 2023 Jul; 15(4):453-461. PubMed ID: 36318805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence and incidence of tuberculosis in people living with the HIV in Mandalay, Myanmar, 2011-2017.
    Phyo KH; Oo MM; Harries AD; Saw S; Aung TK; Moe J; Thuya SS; Mon YY; Min AC; Naing NN; Kyi MS; Aung ST; Oo HN
    Int J Tuberc Lung Dis; 2019 Mar; 23(3):349-357. PubMed ID: 30871667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia.
    Hailu GG; Wasihun AG
    BMC Infect Dis; 2021 Jun; 21(1):561. PubMed ID: 34118891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar.
    Bermúdez-Aza EH; Shetty S; Ousley J; Kyaw NTT; Soe TT; Soe K; Mon PE; Tun KT; Ciglenecki I; Cristofani S; Fernandez M
    PLoS One; 2018; 13(2):e0191695. PubMed ID: 29420652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy.
    Silveira MP; Silveira CP; Guttier MC; Page K; Moreira LB
    J Clin Pharm Ther; 2016 Dec; 41(6):689-694. PubMed ID: 27676134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of second-line antiretroviral treatment in an adult and adolescent cohort in Myanmar.
    Kyaw NTT; Kumar AMV; Oo MM; Oo HN; Kyaw KWY; Thiha S; Aung TK; Win T; Mon YY; Harries AD
    Glob Health Action; 2017; 10(1):1290916. PubMed ID: 28594295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.